Replies to post #208221 on Innovation Pharmaceuticals Inc (IPIX)

[Pepperchino]

Good point, I’ve been following the discussion on this... keep the trial design the same (rinse and spit) to be consistent with the Ph2 design and reduce chances of 2 arms needed for the ph3... agreed and would think the other successful B trials will factor into a single arm Ph3 determination.